The investigational cell therapy deramiocel slowed upper limb functional decline in boys and young men with Duchenne muscular ...

The "Cone Rod Dystrophy Market: 2026 Edition" has been added to ResearchAndMarkets.com's offering. The global cone rod dystrophy market is witnessing substantial growth, with its value projected to ...

OKLAHOMA CITY - Some ride motorcycles for fun, some ride for sport, but Pat Cornell rides for passion. “It started out ...

At Sarepta Therapeutics, we’ve seen it all. Here are the questions I believe we should be asking to move forward in Duchenne ...

A disabled Twitch streamer known for beating difficult games with his chin has returned to the platform to beat Super Mario ...

More than 1,000 stores support pinup and roundup campaigns to help kids and young adults living with neuromuscular diseases ...

Roche Holding said it would start a late-stage study for a gene therapy for Duchenne muscular dystrophy to seek approval in the European Union after drug regulators in the bloc turned it down last ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it ...

The FDA is signaling change, but actual success depends on more than simply bringing in a new leader at the Center for ...

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.

“What I really want people to notice is the stubborn part of me that keeps moving forward.” Living with Muscular Dystrophy and Asperger’s Syndrome, 21-year-old Aaron Sim, a computer science student at ...

Osmond enjoyed the support of his siblings and his own children as he reconfigured his life ...